379 related articles for article (PubMed ID: 17917828)
1. The number of analyzed lymph nodes - a prognostic factor in colorectal cancer.
Edler D; Ohrling K; Hallström M; Karlberg M; Ragnhammar P
Acta Oncol; 2007; 46(7):975-81. PubMed ID: 17917828
[TBL] [Abstract][Full Text] [Related]
2. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
3. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.
Peschaud F; Benoist S; Julié C; Beauchet A; Penna C; Rougier P; Nordlinger B
Ann Surg; 2008 Dec; 248(6):1067-73. PubMed ID: 19092352
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.
Rosenberg R; Friederichs J; Schuster T; Gertler R; Maak M; Becker K; Grebner A; Ulm K; Höfler H; Nekarda H; Siewert JR
Ann Surg; 2008 Dec; 248(6):968-78. PubMed ID: 19092341
[TBL] [Abstract][Full Text] [Related]
5. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
6. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients.
Rosenberg R; Engel J; Bruns C; Heitland W; Hermes N; Jauch KW; Kopp R; Pütterich E; Ruppert R; Schuster T; Friess H; Hölzel D
Ann Surg; 2010 Jun; 251(6):1070-8. PubMed ID: 20485149
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of lymph node ratio in stage III colorectal cancer.
Wong KP; Poon JT; Fan JK; Law WL
Colorectal Dis; 2011 Oct; 13(10):1116-22. PubMed ID: 20874800
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
[TBL] [Abstract][Full Text] [Related]
10. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
11. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
12. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.
Berger AC; Sigurdson ER; LeVoyer T; Hanlon A; Mayer RJ; Macdonald JS; Catalano PJ; Haller DG
J Clin Oncol; 2005 Dec; 23(34):8706-12. PubMed ID: 16314630
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.
Berberoglu U
Hepatogastroenterology; 2004; 51(60):1689-93. PubMed ID: 15532806
[TBL] [Abstract][Full Text] [Related]
14. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
[TBL] [Abstract][Full Text] [Related]
16. [Impact of number of retrieved lymph nodes and lymph node ratio on the prognosis in patients with stage II and III colorectal cancer].
Shao XL; Han HQ; He XL; Fu Q; Lv YC; Liu G
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Apr; 14(4):249-53. PubMed ID: 21538264
[TBL] [Abstract][Full Text] [Related]
17. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
Yano H; Saito Y; Kirihara Y; Takashima J
Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer.
Kim JC; Lee KH; Yu CS; Kim HC; Kim JR; Chang HM; Kim JH; Kim JS; Kim TW
Eur J Surg Oncol; 2004 Apr; 30(3):271-9. PubMed ID: 15028308
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
[TBL] [Abstract][Full Text] [Related]
20. Metastatic lymph node size and colorectal cancer prognosis.
Dhar DK; Yoshimura H; Kinukawa N; Maruyama R; Tachibana M; Kohno H; Kubota H; Nagasue N
J Am Coll Surg; 2005 Jan; 200(1):20-8. PubMed ID: 15631916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
